Ovarian Cancer Latest Advances

Thiol-disulfide homeostasis in ovarian cancer: comparative analysis with benign neoplasia and healthy women.

Journal: Turkish journal of obstetrics and gynecology

Published: April 15, 2026

Integrated machine learning algorithms for prediction of prognosis in ovarian cancer patients based on mitochondrial-related genes.

Journal: Computer methods in biomechanics and biomedical engineering

Published: April 15, 2026

Correction to: Albumin nanoparticles-mediated doxorubicin delivery enhances the anti-tumor efficiency in ovarian cancer cells through controlled release.

Journal: Naunyn-Schmiedeberg's archives of pharmacology

Published: April 14, 2026

Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.

Journal: Annals of the Academy of Medicine, Singapore

Published: April 13, 2026

[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].

Journal: Bulletin du cancer

Published: April 12, 2026

MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Leydig cell ovarian tumour: a rare cause of hyperandrogenism.

Journal: BMJ case reports

Published: April 10, 2026

Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women.

Journal: JAMA network open

Published: April 10, 2026

PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation.

Journal: bioRxiv : the preprint server for biology

Published: April 10, 2026

Letter to the Editor: Methodological Concerns in Bryant et al.'s Network Meta-Analysis on Residual Disease Thresholds in Advanced Ovarian Cancer.

Journal: American journal of therapeutics

Published: April 09, 2026

Retraction: Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis.

Journal: Oncotarget

Published: April 09, 2026

Ovarian Cancer Latest Advances

Find the Latest Research About Ovarian Cancer

Thiol-disulfide homeostasis in ovarian cancer: comparative analysis with benign neoplasia and healthy women.

Thiol-disulfide homeostasis in ovarian cancer: comparative analysis with benign neoplasia and healthy women.

Integrated machine learning algorithms for prediction of prognosis in ovarian cancer patients based on mitochondrial-related genes.

Integrated machine learning algorithms for prediction of prognosis in ovarian cancer patients based on mitochondrial-related genes.

Correction to: Albumin nanoparticles-mediated doxorubicin delivery enhances the anti-tumor efficiency in ovarian cancer cells through controlled release.

Correction to: Albumin nanoparticles-mediated doxorubicin delivery enhances the anti-tumor efficiency in ovarian cancer cells through controlled release.

Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.

Decentralised germline genetic testing for epithelial ovarian cancer in a tertiary Asian centre.

[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].

[Corrigendum to: "French recommendations for clinical practice, Nice/Saint-Paul-de-Vence 2024-2025: Management of high-grade ovarian epithelial cancer" [Bull Cancer 2026;113:191-207]].

MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer.

MRPL47 as a Novel Mitochondrial Biomarker for Early Detection and Therapeutic Response in Ovarian Cancer.

Leydig cell ovarian tumour: a rare cause of hyperandrogenism.

Leydig cell ovarian tumour: a rare cause of hyperandrogenism.

Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women.

Residential Radon Levels and Ovarian Cancer Among Postmenopausal Women.

PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.

PARP16 is a Druggable Regulator of Ribosome MARylation and Protein Homeostasis in Ovarian Cancer Cells.

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation.

Comparative single-cell atlases reveal injury-driven tubal epithelial regeneration as a window for ovarian carcinoma initiation.

Letter to the Editor: Methodological Concerns in Bryant et al.'s Network Meta-Analysis on Residual Disease Thresholds in Advanced Ovarian Cancer.

Letter to the Editor: Methodological Concerns in Bryant et al.'s Network Meta-Analysis on Residual Disease Thresholds in Advanced Ovarian Cancer.

Retraction: Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis.

Retraction: Efficacy and safety of traditional chemotherapies for patients with ovarian neoplasm: a network meta-analysis.